Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > 2 new Board members

<< Previous

Bullboard Posts

Next >>

Comment by aldo451on Sep 01, 2020 11:30am

188 Views

Post# 31486485

RE:2 new Board members

Hi Stockbuphoon,

we actually have one less T.V. rep on the board, Stefan an Zack are gone.

Mr. Krstajic and Mr. Siklos are being appointed to the Board of Directors to fill the vacancies caused by the resignations of Mr. Stefan Clulow and Mr. Zachary Newton.

A quick search shows both as having very successful careers.

On a different note, Ken reiterated BLA filing for this quarter!

”With our BLA filing for Ryplazim expected this quarter and a potential commercial launch of Ryplazim in the US in 2021 if our BLA is approved by the FDA, the extensive business and investment experience of Mr. Krstajic and Mr. Siklos will be valuable to the Board of Directors as we continue to position our business for successful, long-term growth.”

growth.”

stockbuphoon wrote: Another Thomvest guy - President this time. And then a telecom guy from Canada. Great, more Thomvest. Maybe they can reduce spending at least?

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs